Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

DLK is a novel immunohistochemical marker for adrenal gland tumors.

Turányi E, Dezso K, Paku S, Nagy P.

Virchows Arch. 2009 Sep;455(3):295-9. doi: 10.1007/s00428-009-0819-6. Epub 2009 Aug 14.

PMID:
19685073
2.
4.

Delta-like protein (DLK) is a novel immunohistochemical marker for human hepatoblastomas.

Dezso K, Halász J, Bisgaard HC, Paku S, Turányi E, Schaff Z, Nagy P.

Virchows Arch. 2008 Apr;452(4):443-8. doi: 10.1007/s00428-007-0571-8. Epub 2008 Jan 31.

PMID:
18236070
5.

Synaptophysin and neurofilament proteins as markers for neuroendocrine tumors.

Miettinen M.

Arch Pathol Lab Med. 1987 Sep;111(9):813-8.

PMID:
2820344
6.

Diagnostic role of inhibin α-subunit and inhibin/activin β-subunit in adrenal cortical and medullary tumors in Egyptian patients.

Elmoneim HM, Samaka RM, Ali H.

Appl Immunohistochem Mol Morphol. 2012 Oct;20(5):462-9. doi: 10.1097/PAI.0b013e318239e18d.

PMID:
22417854
7.
8.
9.

Histologic and immunohistochemical classification of 41 bovine adrenal gland neoplasms.

Grossi AB, Leifsson PS, Jensen HE, Vainer B, Iburg T.

Vet Pathol. 2013 May;50(3):534-42. doi: 10.1177/0300985812469638. Epub 2012 Dec 14.

PMID:
23242804
10.

Dopamine receptor expression and function in human normal adrenal gland and adrenal tumors.

Pivonello R, Ferone D, de Herder WW, de Krijger RR, Waaijers M, Mooij DM, van Koetsveld PM, Barreca A, De Caro ML, Lombardi G, Colao A, Lamberts SW, Hofland LJ.

J Clin Endocrinol Metab. 2004 Sep;89(9):4493-502.

PMID:
15356054
11.

Distinguishing clear cell renal cell carcinoma, retroperitoneal paraganglioma, and adrenal cortical lesions on limited biopsy material: utility of immunohistochemical markers.

Lapinski JE, Chen L, Zhou M.

Appl Immunohistochem Mol Morphol. 2010 Oct;18(5):414-21. doi: 10.1097/PAI.0b013e3181ddf7b9.

PMID:
20861762
12.

[Pheochromocytoma--pathohistologic and immunohistochemical aspects].

Tatić S, Havelka M, Paunović I, Bozić V, Diklic A, Brasanac D, Janković R, Jancić-Zguricas M.

Srp Arh Celok Lek. 2002 Jul;130 Suppl 2:7-13. Serbian.

PMID:
12584991
13.

Class III beta-tubulin isotype (beta III) in the adrenal medulla: II. Localization in primary human pheochromocytomas.

Karkavelas G, Katsetos CD, Geddes JF, Herman MM, Vinores SA, Cooper HS, Provencio J, Frankfurter A.

Anat Rec. 1998 Mar;250(3):344-50.

PMID:
9517851
14.

Diagnostic Utility of Orthopedia Homeobox (OTP) in Pulmonary Carcinoid Tumors.

Nonaka D, Papaxoinis G, Mansoor W.

Am J Surg Pathol. 2016 Jun;40(6):738-44. doi: 10.1097/PAS.0000000000000621.

PMID:
26927888
15.

[New aspects of tumor pathology of the adrenal glands].

Saeger W.

Pathologe. 2015 May;36(3):301-9. doi: 10.1007/s00292-015-0020-4. Review. German.

PMID:
25941097
16.

Pheochromocytomas and Paragangliomas: An Update on Recent Molecular Genetic Advances and Criteria for Malignancy.

Guo Z, Lloyd RV.

Adv Anat Pathol. 2015 Sep;22(5):283-93. doi: 10.1097/PAP.0000000000000086. Review.

PMID:
26262510
17.

Inhibin/activin betaB-subunit expression in pheochromocytomas favors benign diagnosis.

Salmenkivi K, Arola J, Voutilainen R, Ilvesmäki V, Haglund C, Kahri AI, Heikkilä P, Liu J.

J Clin Endocrinol Metab. 2001 May;86(5):2231-5.

PMID:
11344232
18.

[Diagnostic value of A103 and inhibin-alpha in adrenocortical tumors: an immunohistochemical study using tissue microarray techniques].

Zhang HY, Wang XJ, Liu WP, Jiang LL, Li GD, Guo J, Zhang YH.

Zhonghua Bing Li Xue Za Zhi. 2004 Jun;33(3):203-7. Chinese.

PMID:
15256108
19.

BCL-2 expression and inhibin-A in adrenal neoplasms: a comparative study.

Fogt F, Zimmerman RL, Mulligan N, Vortmeyer AO, Poremba C, Harris CA, Alsaigh N, Tomaszewski JE, Nikulasson ST.

Int J Mol Med. 1999 Mar;3(3):271-4.

PMID:
10028050
20.

The alpha subunit of inhibin in adrenal cortical neoplasia.

Pelkey TJ, Frierson HF Jr, Mills SE, Stoler MH.

Mod Pathol. 1998 Jun;11(6):516-24.

PMID:
9647588

Supplemental Content

Support Center